Target intelligence / Profile preview

Voltage-dependent anion-selective channel protein 1 (VDAC1) (VDAC1)

Target
VDAC1
Molecular classification
Ion channel, Porin, Mitochondrial outer membrane protein, Transporter
01

Overview

Voltage-dependent anion-selective channel protein 1 (VDAC1), frequently referred to as mitochondrial porin, is a 30 kDa beta-barrel protein located in the outer mitochondrial membrane. It functions as the primary conduit for the exchange of ions and essential metabolites, such as ATP, ADP, and respiratory substrates, between the mitochondria and the cytoplasm, thereby acting as a gatekeeper of mitochondrial metabolism (1.2.1, 1.2.3). In cancer cells, VDAC1 is typically overexpressed and associates with hexokinase to promote the Warburg effect and suppress apoptosis, making its inhibition or the disruption of its protein-protein interactions a viable strategy for inducing tumor cell death (1.3.2, 1.3.5). Conversely, in neurodegenerative conditions like Alzheimer's and Parkinson's diseases, VDAC1 is implicated in pathological mitochondrial permeabilization and cell death, where its modulation may offer neuroprotective benefits (1.2.4, 1.3.1). Drugs targeting VDAC1, such as erastin and VBIT-4, aim to either induce ferroptosis or prevent harmful oligomerization, highlighting its versatility as a therapeutic target across multiple disease areas (1.3.3, 1.3.4).

Other names
Mitochondrial porinVDAC1VDAC-1Porin 31HLPorin 31HMOuter mitochondrial membrane protein porin 1Plasmalemmal porin
02

Mechanism of action

Modulation of mitochondrial outer membrane permeability, inhibition of VDAC1 oligomerization, and disruption of VDAC1-hexokinase interactions to regulate metabolic flux and apoptosis.

03

Biological functions

Metabolite transportIon transportApoptosis regulationMitochondrial bioenergeticsCalcium homeostasisCell death signaling
04

Disease associations

CancerAlzheimer's diseaseAmyotrophic lateral sclerosisParkinson's diseaseCardiovascular diseaseType 2 diabetesViral infection
05

Safety considerations

Potential for systemic mitochondrial toxicityOff-target effects on high-energy tissues like the heart and brainComplexity of dual pro- and anti-apoptotic roles
06

Interacting drugs

Erastin

8 more in the full profile.

07

Biomarkers

VDAC1 protein expression levelsVDAC1 mRNA levelsVDAC1 oligomerization stateMitochondrial membrane potential

Beyond the preview

Go deeper on Voltage-dependent anion-selective channel protein 1 (VDAC1) (VDAC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent anion-selective channel protein 1 (VDAC1) (VDAC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call